1. Home
  2. SNGX vs MITQ Comparison

SNGX vs MITQ Comparison

Compare SNGX & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.44

Market Cap

14.4M

Sector

Health Care

ML Signal

HOLD

Logo Moving iMage Technologies Inc.

MITQ

Moving iMage Technologies Inc.

HOLD

Current Price

$0.67

Market Cap

7.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
MITQ
Founded
1987
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
14.4M
7.4M
IPO Year
1987
2021

Fundamental Metrics

Financial Performance
Metric
SNGX
MITQ
Price
$1.44
$0.67
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
426.9K
36.5K
Earning Date
11-07-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$18,477,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$0.50
52 Week High
$6.23
$1.66

Technical Indicators

Market Signals
Indicator
SNGX
MITQ
Relative Strength Index (RSI) 49.69 43.86
Support Level $1.34 $0.62
Resistance Level $1.49 $0.67
Average True Range (ATR) 0.10 0.04
MACD 0.01 0.00
Stochastic Oscillator 79.31 44.78

Price Performance

Historical Comparison
SNGX
MITQ

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: